Short Interest in iCoreConnect Inc. (NASDAQ:ICCT) Drops By 37.3%

iCoreConnect Inc. (NASDAQ:ICCT) saw a significant decline in short interest in the month of February. As of February 15th, there was short interest totalling 46,300 shares, a decline of 37.3% from the January 31st total of 73,900 shares. Based on an average daily volume of 620,500 shares, the days-to-cover ratio is presently 0.1 days. Approximately 3.3% of the company’s shares are sold short.

iCoreConnect Trading Down 11.9 %

NASDAQ:ICCT traded down $0.09 during trading hours on Monday, reaching $0.69. 318,221 shares of the stock were exchanged, compared to its average volume of 304,091. iCoreConnect has a twelve month low of $0.67 and a twelve month high of $35.80. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 7.93. The business has a 50-day moving average of $2.31 and a two-hundred day moving average of $5.05. The company has a market capitalization of $1.43 million, a price-to-earnings ratio of -0.01 and a beta of 0.87.

Hedge Funds Weigh In On iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Virtu Financial LLC purchased a new position in shares of iCoreConnect Inc. (NASDAQ:ICCT) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned approximately 1.04% of iCoreConnect as of its most recent filing with the Securities & Exchange Commission. 13.42% of the stock is owned by institutional investors and hedge funds.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.